Notice: This CMS-approved document has been submitted - Philips ...

CMS-1403-FC
G0332). The Medicare payment rates for IVIG products are
established through the Part B average sales price (ASP)
drug payment methodology.
As explained in detail in the CY 2006, CY 2007 and CY
2008 PFS final rules with comment period (70 FR 70218 to
70221, 71 FR 69678 to 69679, and 72 FR 66254 to 66255,
respectively), we created, in 2006, a temporary code in
order to pay separately for the IVIG
preadministration-related services in order to assist in
ensuring appropriate access to IVIG during a period of
market instability. Part of this instability was due to
the implementation of the new ASP payment methodology for
IVIG drugs which began in 2005. The payment for
preadministration-related services was continued in 2007
and 2008 because of continued reported instability in the
IVIG marketplace. The preadministration-related payment
was designed to pay the physician practice for the added
costs of obtaining adequate supplies of the appropriate
IVIG product and scheduling the patient infusion during a
period of market uncertainty.
The PFS rates for the pre-administration service codes
were $72, $75, and $75 respectively in 2006, 2007, and
2008.
123